Bank of America’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-41,836
Closed -$24.2K 8572
2024
Q3
$24.2K Sell
41,836
-43,171
-51% -$24.2K ﹤0.01% 6709
2024
Q2
$52.4K Sell
85,007
-332
-0.4% -$281 ﹤0.01% 6501
2024
Q1
$219K Sell
85,339
-102,191
-54% -$250K ﹤0.01% 5834
2023
Q4
$383K Buy
187,530
+142,850
+320% +$261K ﹤0.01% 5684
2023
Q3
$76.8K Buy
44,680
+2,993
+7% +$5.31K ﹤0.01% 6359
2023
Q2
$81.3K Sell
41,687
-1,018,551
-96% -$2.39M ﹤0.01% 6281
2023
Q1
$2.95M Buy
1,060,238
+934,149
+741% +$2.67M ﹤0.01% 4025
2022
Q4
$435K Buy
126,089
+70,852
+128% +$202K ﹤0.01% 5483
2022
Q3
$142K Buy
55,237
+28,500
+107% +$90.7K ﹤0.01% 6169
2022
Q2
$65K Sell
26,737
-48,444
-64% -$127K ﹤0.01% 6708
2022
Q1
$310K Sell
75,181
-157,231
-68% -$833K ﹤0.01% 6165
2021
Q4
$2.99M Buy
232,412
+211,548
+1,014% +$2.34M ﹤0.01% 4171
2021
Q3
$225K Buy
20,864
+7,088
+51% +$64.5K ﹤0.01% 6224
2021
Q2
$125K Sell
13,776
-27,705
-67% -$256K ﹤0.01% 6394
2021
Q1
$391K Buy
41,481
+30,062
+263% +$414K ﹤0.01% 5565
2020
Q4
$45K Sell
11,419
-30,327
-73% -$91.7K ﹤0.01% 6366
2020
Q3
$111K Buy
41,746
+21,699
+108% +$80.5K ﹤0.01% 5642
2020
Q2
$133K Sell
20,047
-5,427
-21% -$36.5K ﹤0.01% 5520
2020
Q1
$148K Buy
25,474
+6,065
+31% +$50.9K ﹤0.01% 5280
2019
Q4
$174K Buy
19,409
+4,134
+27% +$34.5K ﹤0.01% 5715
2019
Q3
$132K Buy
15,275
+2,879
+23% +$29.1K ﹤0.01% 5908
2019
Q2
$137K Buy
12,396
+10,318
+497% +$118K ﹤0.01% 5832
2019
Q1
$27K Sell
2,078
-781
-27% -$10.4K ﹤0.01% 6417
2018
Q4
$45K Buy
+2,859
New +$54.6K ﹤0.01% 6257

Other funds holding GRTS

Bank of America's GRTS Position: Q4 2024 in Review

Bank of America sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 41,836 shares — an estimated $24.2K sold.

Bank of America first reported a position in GRTS in Q4 2018 and held it in 24 quarters. The position peaked at $2.99M in Q4 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

  • Bank of America reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Bank of America sold 41,836 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $24.2K.
  • Bank of America first reported a position in Gritstone bio, Inc. Common Stock in Q4 2018 and held it in 24 quarters.
  • Bank of America's Gritstone bio, Inc. Common Stock position peaked at $2.99M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Bank of America's 13F filing for Q4 2024, filed 14 Feb 2025.